CTNNB1 and hepatocellular carcinoma: Emerging evidence indicates that CTNNB1 mutations can initiate oncogenic signaling cascades in HCC by promoting the nuclear accumulation of β‐catenin and subsequent activation of Wnt target genes [27, 28].